There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Johnson & Johnson (NYSE: JNJ) has kicked off construction on a $2 billion biologics manufacturing facility in Eastern North ...

BYD Company's aggressive global expansion, flexible pricing and innovative technology position it as a strong contender for ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.

Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli ...

An 11-year-old’s support has inspired the NBA-superstar-turned-coach as his team rolls into the NCAA tournament at Seattle ...

Johnson & Johnson has announced a $55 billion investment in the U.S. over the next four years. This move will boost American ...

Stocks including TCS, Hindalco, HUL, Hero Moto, Asian Paints, Manappuram, Zomato, Glenmark Pharma, PFC and RailTel will be in ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Reports FY24 revenue $89.1M, consensus $18.48M. “Our strong execution throughout 2024 and into 2025 has positioned ARS Pharma for sustained ...

BCE's high debt and Ziply capex needs are likely to force a dividend cut within 12–18 months, negatively impacting share ...